{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T04:30:21Z","timestamp":1786509021245,"version":"build-2736575974"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Diabetol"],"DOI":"10.1007\/s00592-026-02701-9","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T06:32:32Z","timestamp":1779431552000},"page":"1343-1350","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Polycythemia due to SGLT-2 inhibitors: who is at risk?"],"prefix":"10.1007","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-8926-3703","authenticated-orcid":false,"given":"Hediye B\u00fc\u015fra","family":"Erg\u00fcn Ar\u0131kan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3633-9546","authenticated-orcid":false,"given":"G\u00fclay","family":"Ko\u00e7ak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7314-8370","authenticated-orcid":false,"given":"Funda","family":"Yal\u00e7\u0131n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8577-9364","authenticated-orcid":false,"given":"Kadir","family":"Bilgi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6932-0796","authenticated-orcid":false,"given":"Mahmut","family":"Alt\u0131ndal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,22]]},"reference":[{"key":"2701_CR1","doi-asserted-by":"publisher","unstructured":"Salvatore T, et al. (2022) An Overview of the Cardiorenal Protective Mechanisms of SGLT2 Inhibitors. Int J Mol Sci 23(7). https:\/\/doi.org\/10.3390\/ijms23073651","DOI":"10.3390\/ijms23073651"},{"key":"2701_CR2","unstructured":"Diabetes Mellitus \u00c7al\u0131\u015fma ve E\u011fitim Grubu, Accessed: Jun. 16, 2024. [Online]. Available: www.bayt.com.tr"},{"key":"2701_CR3","doi-asserted-by":"publisher","unstructured":"Noumani I, Harrison CN, McMullin MF (2024) Erythrocytosis: diagnosis and investigation. Int J Lab Hematol 46(1):55\u201362. https:\/\/doi.org\/10.1111\/ijlh.14298","DOI":"10.1111\/ijlh.14298"},{"key":"2701_CR4","unstructured":"Macpk. JM, Robert MFMD, Means T (2025) Clinical manifestations and diagnosis of vitamin B12 and folate deficiencie"},{"key":"2701_CR5","unstructured":"Auerbach MFM (2026) Lab Interpretation: abnormal iron profile: low ferritin or low iron in adults"},{"key":"2701_CR6","doi-asserted-by":"publisher","unstructured":"Tian Q, Guo K, Deng J, Zhong Y, Yang L (2022) Effects of SGLT2 inhibitors on haematocrit and haemoglobin levels and the associated cardiorenal benefits in T2DM patients: a meta-analysis. J Cell Mol Med 26(2): 540\u2013547. https:\/\/doi.org\/10.1111\/jcmm.17115","DOI":"10.1111\/jcmm.17115"},{"key":"2701_CR7","doi-asserted-by":"publisher","unstructured":"Kanbay M, et al (2022) Effect of sodium\u2013glucose cotransporter 2 inhibitors on hemoglobin and hematocrit levels in type 2 diabetes: a systematic review and meta-analysis. Int Urol Nephrol 54(4): 827\u2013841. https:\/\/doi.org\/10.1007\/s11255-021-02943-2","DOI":"10.1007\/s11255-021-02943-2"},{"key":"2701_CR8","doi-asserted-by":"publisher","unstructured":"Thiele K, et al (2021) Effects of empagliflozin on erythropoiesis in patients with type 2 diabetes: data from a randomized, placebo-controlled study. Diabetes Obes Metab 23(12): 2814\u20132818. https:\/\/doi.org\/10.1111\/dom.14517","DOI":"10.1111\/dom.14517"},{"key":"2701_CR9","doi-asserted-by":"publisher","unstructured":"Vallon V, Verma S (2021) Effects of SGLT2 inhibitors on kidney and function and cardiovascular. Annu Rev Physiol 83:503. https:\/\/doi.org\/10.1146\/ANNUREV-PHYSIOL-031620-095920","DOI":"10.1146\/ANNUREV-PHYSIOL-031620-095920"},{"issue":"12","key":"2701_CR10","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1002\/ejhf.2731","volume":"24","author":"M Packer","year":"2022","unstructured":"Packer M (2022) How can sodium\u2013glucose cotransporter 2 inhibitors stimulate erythrocytosis in patients who are iron-deficient? Implications for understanding iron homeostasis in heart failure. Eur J Heart Fail 24(12):2287\u20132296. https:\/\/doi.org\/10.1002\/ejhf.2731","journal-title":"Eur J Heart Fail"},{"issue":"12","key":"2701_CR11","doi-asserted-by":"publisher","first-page":"844","DOI":"10.14740\/jocmr2760w","volume":"8","author":"M Sano","year":"2016","unstructured":"Sano M, Takei M, Shiraishi Y, Suzuki Y (2016) Increased hematocrit during sodium-glucose cotransporter 2 inhibitor therapy indicates recovery of tubulointerstitial function in diabetic kidneys. J Clin Med Res 8(12):844\u2013847. https:\/\/doi.org\/10.14740\/jocmr2760w","journal-title":"J Clin Med Res"},{"key":"2701_CR12","doi-asserted-by":"publisher","unstructured":"Ekanayake P, Mudaliar S (2023) Increase in hematocrit with SGLT-2 inhibitors-Hemoconcentration from diuresis or increased erythropoiesis after amelioration of hypoxia? Diabetes Metab Synd Clin Res Reviews 17(2):102702. https:\/\/doi.org\/10.1016\/j.dsx.2022.102702","DOI":"10.1016\/j.dsx.2022.102702"},{"key":"2701_CR13","doi-asserted-by":"publisher","unstructured":"Warren AM, Grossmann M (2022) Haematological actions of androgens. Best Pract Res Clin Endocrinol Metab 36(5):101653. https:\/\/doi.org\/10.1016\/j.beem.2022.101653","DOI":"10.1016\/j.beem.2022.101653"},{"issue":"10","key":"2701_CR14","doi-asserted-by":"publisher","first-page":"680","DOI":"10.2169\/internalmedicine.36.680","volume":"36","author":"N Tanabe","year":"1997","unstructured":"Tanabe N, Ohnishi K, Fukui H, Ohno R (1997) Effect of smoking on the serum concentration of erythropoietin and granulocyte-colony stimulating factor. Intern Med 36(10):680\u2013684. https:\/\/doi.org\/10.2169\/internalmedicine.36.680","journal-title":"Intern Med"},{"key":"2701_CR15","doi-asserted-by":"publisher","unstructured":"Malenica M, et al. (2017) Effect of cigarette smoking on haematological parameters in healthy population. Med Arch 71(2):132\u2013136. https:\/\/doi.org\/10.5455\/medarh.2017.71.132-136","DOI":"10.5455\/medarh.2017.71.132-136"},{"key":"2701_CR16","doi-asserted-by":"publisher","unstructured":"Vicent D, et al. (2003) The role of endothelial insulin signaling in the regulation of vascular tone and insulin resistance. J Clin Invest 111(9):1373\u20131380. https:\/\/doi.org\/10.1172\/JCI15211","DOI":"10.1172\/JCI15211"},{"key":"2701_CR17","doi-asserted-by":"publisher","unstructured":"Sartori C, Scherrer U (1999) Insulin, nitric oxide and the sympathetic nervous system. J Hypertens 17(11): 1517\u20131525. https:\/\/doi.org\/10.1097\/00004872-199917110-00003","DOI":"10.1097\/00004872-199917110-00003"},{"key":"2701_CR18","doi-asserted-by":"publisher","unstructured":"Cardillo C, et al. (1999) Insulin stimulates both endothelin and nitric oxide activity in the human forearm. Circulation 100(8):820\u2013825. https:\/\/doi.org\/10.1161\/01.CIR.100.8.820","DOI":"10.1161\/01.CIR.100.8.820"},{"key":"2701_CR19","doi-asserted-by":"publisher","unstructured":"Suboti\u010dki T, Ajti\u0107 OM, \u0110iki\u0107 D, Santibanez JF, To\u0161i\u0107 M, \u010coki\u0107 VP (2021) Nitric oxide synthase dependency in hydroxyurea inhibition of erythroid progenitor growth. Genes (Basel) 12(8):1145. https:\/\/doi.org\/10.3390\/genes12081145","DOI":"10.3390\/genes12081145"},{"key":"2701_CR20","doi-asserted-by":"publisher","unstructured":"Matsubayashi Y, et al. (2022) Predictors of haemoglobin levels and of changes in these levels, focusing on anaemia and polycythaemia after administration of the <\u2009scp>sodium-glucose cotransporter\u20102 inhibitor tofogliflozin.Diabetes Obes.Metab 24(12): 2469\u20132473. https:\/\/doi.org\/10.1111\/dom.14836","DOI":"10.1111\/dom.14836"},{"key":"2701_CR21","doi-asserted-by":"publisher","unstructured":"Zhang J, et al. (2021) Secondary polycythemia in chronic obstructive pulmonary disease: prevalence and risk factors. BMC Pulm Med 21(1):235. https:\/\/doi.org\/10.1186\/s12890-021-01585-5","DOI":"10.1186\/s12890-021-01585-5"},{"key":"2701_CR22","unstructured":"Vicari AM, Ponzoni M, Alberetto M, Martani C, Pontiroli AE, Folli F (1998) Erythrocytosis in a patient with chronic obstructive pulmonary disease. Haematologica 83(2):183\u2013186"}],"container-title":["Acta Diabetologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-026-02701-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00592-026-02701-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-026-02701-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T04:02:56Z","timestamp":1786507376000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00592-026-02701-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,22]]},"references-count":22,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["2701"],"URL":"https:\/\/doi.org\/10.1007\/s00592-026-02701-9","relation":{},"ISSN":["1432-5233"],"issn-type":[{"value":"1432-5233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,22]]},"assertion":[{"value":"5 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no conflicts of interest to disclose.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the ethics committee of Prof. Dr. Cemil Ta\u015f\u00e7\u0131o\u011flu City Hospital, University of Health Sciences as a result of the meeting held on October, 20, 2023 (decision number: 272). The study was conducted in accordance with the principles of the Declaration of Helsinki.","order":2,"name":"Ethics","label":"Ethics of approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was waived due to the retrospective design of the study.","order":3,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from all patients.","order":4,"name":"Ethics","label":"Patient consent","group":{"name":"EthicsHeading","label":"Declarations"}}]}}